Revisiting the heidenhain variant of creutzfeldt-jakob disease: Evidence for prion type variability influencing clinical course and laboratory findings

Simone Baiardi, Sabina Capellari, Anna Ladogana, Silvia Strumia, Mario Santangelo, Maurizio Pocchiari, Piero Parchi

Research output: Contribution to journalArticle

Abstract

The Heidenhain variant defines a peculiar clinical presentation of sporadic Creutzfeldt-Jakob disease (sCJD) characterized by isolated visual disturbances at disease onset and reflecting the early targeting of prions to the occipital cortex. Molecular and histopathological typing, thus far performed in 23 cases, has linked the Heidenhain variant to the MM1 sCJD type. To contribute a comprehensive characterization of cases with the Heidenhain variant, we reviewed a series of 370 definite sCJD cases. Eighteen patients (4.9) fulfilled the selection criteria. Fourteen of them belonging to sCJD types MM1 or MM12C had a short duration of isolated visual symptoms and overall clinical disease, a high prevalence of periodic sharp-wave complexes in EEG, and a marked increase of cerebrospinal fluid proteins t-tau and 14-3-3 levels. In contrast, three cases of the MM 2C or MM 21C types showed a longer duration of isolated visual symptoms and overall clinical disease, non-specific EEG findings, and cerebrospinal fluid concentration below threshold for the diagnosis of "probable" CJD of both 14-3-3 and t-tau. However, a brain DWI-MRI disclosed an occipital cortical hyperintensity in the majority of examined cases of both groups. While confirming the strong linkage with the methionine genotype at the polymorphic codon 129 of the prion protein gene, our results definitely establish that the Heidenhain variant can also be associated with the MM 2C sCJD type in addition to the more common MM1 type. Likewise, our results highlight the significant differences in clinical evolution and laboratory findings between cases according to the dominant PrPSc type (type 1 versus type 2).

Original languageEnglish
Pages (from-to)465-476
Number of pages12
JournalJournal of Alzheimer's Disease
Volume50
Issue number2
DOIs
Publication statusPublished - 2016

Fingerprint

Prions
Electroencephalography
Cerebrospinal Fluid Proteins
Molecular Typing
Occipital Lobe
Codon
Methionine
Patient Selection
Cerebrospinal Fluid
Genotype
Heidenhain Variant Creutzfeldt-Jakob Disease
Sporadic Creutzfeldt-Jakob Disease
Brain
Genes

Keywords

  • Dementia
  • molecular typing
  • neurodegenerative diseases
  • occipital cortex
  • prion diseases
  • prion protein

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Revisiting the heidenhain variant of creutzfeldt-jakob disease : Evidence for prion type variability influencing clinical course and laboratory findings. / Baiardi, Simone; Capellari, Sabina; Ladogana, Anna; Strumia, Silvia; Santangelo, Mario; Pocchiari, Maurizio; Parchi, Piero.

In: Journal of Alzheimer's Disease, Vol. 50, No. 2, 2016, p. 465-476.

Research output: Contribution to journalArticle

@article{909582d1be9544a7bdd894480a0cfeaf,
title = "Revisiting the heidenhain variant of creutzfeldt-jakob disease: Evidence for prion type variability influencing clinical course and laboratory findings",
abstract = "The Heidenhain variant defines a peculiar clinical presentation of sporadic Creutzfeldt-Jakob disease (sCJD) characterized by isolated visual disturbances at disease onset and reflecting the early targeting of prions to the occipital cortex. Molecular and histopathological typing, thus far performed in 23 cases, has linked the Heidenhain variant to the MM1 sCJD type. To contribute a comprehensive characterization of cases with the Heidenhain variant, we reviewed a series of 370 definite sCJD cases. Eighteen patients (4.9) fulfilled the selection criteria. Fourteen of them belonging to sCJD types MM1 or MM12C had a short duration of isolated visual symptoms and overall clinical disease, a high prevalence of periodic sharp-wave complexes in EEG, and a marked increase of cerebrospinal fluid proteins t-tau and 14-3-3 levels. In contrast, three cases of the MM 2C or MM 21C types showed a longer duration of isolated visual symptoms and overall clinical disease, non-specific EEG findings, and cerebrospinal fluid concentration below threshold for the diagnosis of {"}probable{"} CJD of both 14-3-3 and t-tau. However, a brain DWI-MRI disclosed an occipital cortical hyperintensity in the majority of examined cases of both groups. While confirming the strong linkage with the methionine genotype at the polymorphic codon 129 of the prion protein gene, our results definitely establish that the Heidenhain variant can also be associated with the MM 2C sCJD type in addition to the more common MM1 type. Likewise, our results highlight the significant differences in clinical evolution and laboratory findings between cases according to the dominant PrPSc type (type 1 versus type 2).",
keywords = "Dementia, molecular typing, neurodegenerative diseases, occipital cortex, prion diseases, prion protein",
author = "Simone Baiardi and Sabina Capellari and Anna Ladogana and Silvia Strumia and Mario Santangelo and Maurizio Pocchiari and Piero Parchi",
note = "Ricercatori distaccati presso IRCCS a seguito Convenzione esclusiva con Universit{\`a} di Bologna (Capellari Sabina, Parchi Piero)",
year = "2016",
doi = "10.3233/JAD-150668",
language = "English",
volume = "50",
pages = "465--476",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Revisiting the heidenhain variant of creutzfeldt-jakob disease

T2 - Evidence for prion type variability influencing clinical course and laboratory findings

AU - Baiardi, Simone

AU - Capellari, Sabina

AU - Ladogana, Anna

AU - Strumia, Silvia

AU - Santangelo, Mario

AU - Pocchiari, Maurizio

AU - Parchi, Piero

N1 - Ricercatori distaccati presso IRCCS a seguito Convenzione esclusiva con Università di Bologna (Capellari Sabina, Parchi Piero)

PY - 2016

Y1 - 2016

N2 - The Heidenhain variant defines a peculiar clinical presentation of sporadic Creutzfeldt-Jakob disease (sCJD) characterized by isolated visual disturbances at disease onset and reflecting the early targeting of prions to the occipital cortex. Molecular and histopathological typing, thus far performed in 23 cases, has linked the Heidenhain variant to the MM1 sCJD type. To contribute a comprehensive characterization of cases with the Heidenhain variant, we reviewed a series of 370 definite sCJD cases. Eighteen patients (4.9) fulfilled the selection criteria. Fourteen of them belonging to sCJD types MM1 or MM12C had a short duration of isolated visual symptoms and overall clinical disease, a high prevalence of periodic sharp-wave complexes in EEG, and a marked increase of cerebrospinal fluid proteins t-tau and 14-3-3 levels. In contrast, three cases of the MM 2C or MM 21C types showed a longer duration of isolated visual symptoms and overall clinical disease, non-specific EEG findings, and cerebrospinal fluid concentration below threshold for the diagnosis of "probable" CJD of both 14-3-3 and t-tau. However, a brain DWI-MRI disclosed an occipital cortical hyperintensity in the majority of examined cases of both groups. While confirming the strong linkage with the methionine genotype at the polymorphic codon 129 of the prion protein gene, our results definitely establish that the Heidenhain variant can also be associated with the MM 2C sCJD type in addition to the more common MM1 type. Likewise, our results highlight the significant differences in clinical evolution and laboratory findings between cases according to the dominant PrPSc type (type 1 versus type 2).

AB - The Heidenhain variant defines a peculiar clinical presentation of sporadic Creutzfeldt-Jakob disease (sCJD) characterized by isolated visual disturbances at disease onset and reflecting the early targeting of prions to the occipital cortex. Molecular and histopathological typing, thus far performed in 23 cases, has linked the Heidenhain variant to the MM1 sCJD type. To contribute a comprehensive characterization of cases with the Heidenhain variant, we reviewed a series of 370 definite sCJD cases. Eighteen patients (4.9) fulfilled the selection criteria. Fourteen of them belonging to sCJD types MM1 or MM12C had a short duration of isolated visual symptoms and overall clinical disease, a high prevalence of periodic sharp-wave complexes in EEG, and a marked increase of cerebrospinal fluid proteins t-tau and 14-3-3 levels. In contrast, three cases of the MM 2C or MM 21C types showed a longer duration of isolated visual symptoms and overall clinical disease, non-specific EEG findings, and cerebrospinal fluid concentration below threshold for the diagnosis of "probable" CJD of both 14-3-3 and t-tau. However, a brain DWI-MRI disclosed an occipital cortical hyperintensity in the majority of examined cases of both groups. While confirming the strong linkage with the methionine genotype at the polymorphic codon 129 of the prion protein gene, our results definitely establish that the Heidenhain variant can also be associated with the MM 2C sCJD type in addition to the more common MM1 type. Likewise, our results highlight the significant differences in clinical evolution and laboratory findings between cases according to the dominant PrPSc type (type 1 versus type 2).

KW - Dementia

KW - molecular typing

KW - neurodegenerative diseases

KW - occipital cortex

KW - prion diseases

KW - prion protein

UR - http://www.scopus.com/inward/record.url?scp=84969794905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969794905&partnerID=8YFLogxK

U2 - 10.3233/JAD-150668

DO - 10.3233/JAD-150668

M3 - Article

C2 - 26682685

AN - SCOPUS:84969794905

VL - 50

SP - 465

EP - 476

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -